Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
DOCUSATE SODIUM PRO DOC LIMITEE Actual shortage 100MG Updated Report 2024-12-04 241984
DEPO-MEDROL 80 MG/ML PFIZER CANADA ULC Anticipated shortage 80MG Updated Report 2024-12-04 242131
MDK-NITISINONE MENDELIKABS INC Anticipated shortage 5MG Updated Report 2024-12-04 239658
M-ESLON ETHYPHARM INC Anticipated shortage 200MG New Report 2024-12-04 244743
TAMSULOSIN CR SANIS HEALTH INC Actual shortage 0.4MG Updated Report 2024-12-04 230839
PRAMIPEXOLE SANIS HEALTH INC Actual shortage 0.25MG Updated Report 2024-12-04 242419
GABAPENTIN SANIS HEALTH INC Actual shortage 300MG Updated Report 2024-12-04 243265
BETAHISTINE SANIS HEALTH INC Actual shortage 24MG New Report 2024-12-04 244732
PHENYLEPHRINE HYDROCHLORIDE INJECTION USP 1% OMEGA LABORATORIES LIMITED Resolved 10MG Updated Report 2024-12-04 157872
NALOXONE HYDROCHLORIDE INJECTION OMEGA LABORATORIES LIMITED Resolved 1MG Updated Report 2024-12-04 102929
NALOXONE HYDROCHLORIDE INJECTION OMEGA LABORATORIES LIMITED Resolved 0.4MG Updated Report 2024-12-04 102920
RITUXAN SC HOFFMANN-LA ROCHE LIMITED Resolved 1400MG Updated Report 2024-12-04 243448
MONTELUKAST SANIS HEALTH INC Resolved 5MG Updated Report 2024-12-04 76275
MONTELUKAST SANIS HEALTH INC Resolved 5MG Updated Report 2024-12-04 81977
LEUCOVORIN CALCIUM INJECTION USP PFIZER CANADA ULC Resolved 10MG Updated Report 2024-12-04 220361
METHOTREXATE INJECTION USP PFIZER CANADA ULC Actual shortage 25MG Updated Report 2024-12-04 239730
AURO-VALSARTAN HCT AURO PHARMA INC Actual shortage 12.5MG 160MG Updated Report 2024-12-04 235918
ATOVAQUONE PROGUANIL SANIS HEALTH INC Resolved 100MG 250MG Updated Report 2024-12-04 236964
AA-THEO LA AA PHARMA INC Actual shortage 200MG Updated Report 2024-12-04 244126
VENLAFAXINE XR JAMP PHARMA CORPORATION Actual shortage 75MG Updated Report 2024-12-03 183736

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
LAMISIL NOVARTIS PHARMACEUTICALS CANADA INC To be discontinued 250MG Updated Report 2024-11-28 244096
FLAREX NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 0.1% Updated Report 2024-11-28 235987
ERFA-AMIKACIN SEARCHLIGHT PHARMA INC Discontinued 250MG New Report 2024-11-27 243998
HUMALOG ELI LILLY CANADA INC To be discontinued 100UNIT Updated Report 2024-11-27 224347
MICAFUNGIN SODIUM FOR INJECTION JUNO PHARMACEUTICALS CORP. Discontinued 100MG Updated Report 2024-11-26 243753
FLAGYL SANOFI-AVENTIS CANADA INC Discontinued 10% Updated Report 2024-11-20 223877
INVOKAMET JANSSEN INC Discontinued 500MG 150MG Updated Report 2024-11-13 230850
PEDIACEL SANOFI PASTEUR LIMITED Discontinued 5MCG 20MCG 30MCG 10MCG 32UNIT 8UNIT 40UNIT 5LF 15LF 20MCG 3MCG Updated Report 2024-11-11 206912
AUBAGIO SANOFI-AVENTIS CANADA INC Discontinued 14MG Updated Report 2024-11-09 226847
GAVRETO HOFFMANN-LA ROCHE LIMITED To be discontinued 100MG New Report 2024-11-06 242142
AERMONY RESPICLICK TEVA CANADA LIMITED Discontinued 55MCG New Report 2024-11-05 242101
DORZOLAMIDE AND TIMOLOL EYE DROPS BP HIKMA CANADA LIMITED Discontinued 5MG 20MG New Report 2024-11-01 241852
PEDIACEL SANOFI PASTEUR LIMITED Discontinued 5MCG 20MCG 30MCG 10MCG 26UNIT 7UNIT 29UNIT 5LF 15LF 20MCG 3MCG New Report 2024-11-01 241815
DALACIN C 300 MG PFIZER CANADA ULC Discontinued 300MG Updated Report 2024-10-30 241493
PANTOPRAZOLE SODIUM FOR INJECTION SANDOZ CANADA INCORPORATED Discontinued 40MG New Report 2024-10-29 241520
IMDUR JUNO PHARMACEUTICALS CORP. Discontinued 60MG Updated Report 2024-10-29 233587
TD ADSORBED SANOFI PASTEUR LIMITED Discontinued 5LF 2LF Updated Report 2024-10-25 206909
HUMATROPE ELI LILLY CANADA INC To be discontinued 24MG 3.15ML New Report 2024-10-18 240682
HUMATROPE ELI LILLY CANADA INC To be discontinued 12MG 3.15ML New Report 2024-10-18 240679
HUMATROPE ELI LILLY CANADA INC To be discontinued 6MG 3.15ML New Report 2024-10-18 240676